Rare Diseases Activities
Treating Chronic Inflammatory Demyelinating Polyneuropathy With Immunoglobulin: Strategies for Appropriate Use and Accurate Dosing
0290-0000-20-095-L01-P
This live virtual symposium will examine the pathophysiology of chronic inflammatory demyelinating polyneuropathy (CIDP).
6-16-2020
1.00
Examining the Use of Immunoglobulin for Primary Immunodeficiency Disorders
0290-0000-20-077-H01-P
This activity will prepare pharmacists to make determinations about patient eligibility for subcutaneous or intravenous IG administration, considerations for switching, and educate them about appropriate stewardship of IG products to optimize outcomes for patients with PIDs.
2.00
Examining Best Practices for Specialty Pharmacists to Improve the Care of Patients With α1-Antitrypsin Deficiency
0290-0000-19-248-H01-P
This activity will investigate the available therapies for AATD by understanding key characteristics including mechanism of action and efficacy
2.00
A Managed Care Perspective on the Value of Early Recognition, Current Treatments, and Healthcare Utilization Associated with Amyotrophic Lateral Sclerosis
0290-0000-19-241-H01-P
This activity will highlight the value of early diagnosis, early initiation, treatment options, and economic data regarding healthcare services necessary for patients living with ALS.
1.00